Navigation Links
FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents
Date:7/28/2009

PHILADELPHIA, July 28 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has received a Complete Response letter today for INTUNIV(TM) (guanfacine) Extended Release from the Food and Drug Administration (FDA). This decision comes following labeling discussions with the FDA that did not result in agreement in time to meet the PDUFA date.

The FDA did not identify safety concerns regarding INTUNIV in the Complete Response letter or request new clinical studies. Shire and the FDA will continue to work together to resolve the remaining labeling language over the next 4 to 8 weeks.

"Shire is confident that we will quickly come to agreement on the final product label and anticipates a launch in the fourth quarter as planned," said Mike Cola, President of Shire Specialty Pharmaceuticals. "When approved, INTUNIV will be the first selective alpha-2A receptor agonist for the treatment of ADHD, and will provide patients with an important new treatment option."

About INTUNIV

INTUNIV is being studied for the treatment of ADHD in children and adolescents aged 6 to 17 years. INTUNIV is a once-daily, extended release formulation of guanfacine, designed to provide steady delivery of drug throughout the day. INTUNIV is not a controlled substance and has no known potential for abuse or dependence.

Guanfacine, the active ingredient in INTUNIV, is thought to work directly by binding selectively to alpha-2A adrenergic receptors located in the prefrontal cortex - an area of the brain that has been linked to ADHD.(4-6) Stimulation of the postsynaptic alpha-2A receptors is thought to strengthen working memory, reduce susceptibility to distraction, improve attention regulation, improve behavioral inhibition and enhance
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
3. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , NATICK, Mass. and LONDON, Nov. 20 /P...ion (NYSE: BSX ) today announced that it has rec... Administration (FDA) and CE Mark approval to mark...nt for the treatment of malignant esophageal stric...with resectable or non-resectable esophageal cance...
(Date:11/20/2009)..., , HOUSTON, Nov. 20 /PRNewswire-FirstC...nounced that Dan Moore, President and Chief Execut...cer, will present at the 21st Annual Piper Jaffray...December 2, 2009 at 12:00 PM EST. The conference ...al slides will be presented. Piper Jaffray will h...
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewsw...y) (NYSE: BDX ) today announced the completion o... Michigan-based company that develops and manufact...atforms. ,, In May 2009, BD and HandyLab announ...ommercialize molecular assays on the HandyLab Jagu...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Drug Might Restore Sense of Smell 51357 1Drug Might Restore Sense of Smell 51357 2Drug Might Restore Sense of Smell 51357 3Texas Humane Legislation Network Calls for Puppy Mill Crackdown 51352 1Texas Humane Legislation Network Calls for Puppy Mill Crackdown 51352 2New Poll Shows Americans Continuing to Move Toward Pro Life Position on Abortion 51348 1New Poll Shows Americans Continuing to Move Toward Pro Life Position on Abortion 51348 2
...7 The Department of,Justice announced today that ...e on Cancer (CRC) to develop and publicize model c...new cancer treatments. The Department said,the lan...be used to help,increase efficiency in contract ne...ing the time needed to begin clinical trials., Th...
...pt. 17 Sanofi pasteur, the,vaccines division of t...s,sponsoring a Phase II clinical study exploring a... advanced-stage melanoma -- an often fatal form of...ons. Patients are being,enrolled in the United Sta...stigate the safety and efficacy of a therapeutic c...
Other Medicine Technology:Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 3Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 4Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 5
(Date:11/20/2009)...swire-USNewswire/ -- The United States Conference ...tial changes its health reform bill in order to ke...nscience protection on abortion, protect access to...visions for adequate affordability. ,, The bish...s disappointment" that creates new and unacceptabl...
(Date:11/20/2009)...wswire-FirstCall/ -- Rates of infection by the 200...ober, but the pandemic flu virus continues to be a...cluding the elderly, according to a new report by ... world,s leading provider of diagnostic testing, i... Quest Diagnostics Health Trends(TM) Report "Testi...
(Date:11/20/2009)...20 Cardio Vascular,Medic....COM , a leading,developer of advanced cardiovascu...ompany,s Board of Directors has decided to initiat...r East for its proprietary next-generation,"steera...A) procedures. , Cardio Vascular Medical ...
(Date:11/20/2009)...ire-FirstCall/ -- SIRIUS XM Radio (Nasdaq: SIRI... Radio Reports: What Every Women Needs to Know Ab...eran journalist Perri Peltz. ,, (Logo: http:/... ) ,, Doctor Radio Reports: What Every Woman...er 21 live at 10:00 am ET on Doctor Radio , SIRIU...
(Date:11/20/2009)... with chronic kidney disease often fail to detect ...increasing a child,s risk for serious heart proble...ren,s Center and other institutions. A report of t...can Society of Nephrology. , Researchers compa...gular doctor visits to readings obtained via a spe...
Breaking Medicine News(10 mins):Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:High blood pressure easy to miss in children with kidney disease 2
...mber 11, 2007 Takeda Pharmaceuticals North Americ...one HCl) data conducted by A. Michael Lincoff, M.D...ed in the Journal of the American Medical Associat...tients with diabetes versus control therapy. , ...
...ostate biopsies resulted in a cancer diagnosis amo...e first biopsy did not find cancer often had multi...ance of a cancer diagnosis. , While PSA (prostat...Nonetheless, it remains unclear whether or not PSA...
...n now have another good reason to consider taking ...s an enlarged prostate and reduces the risk of get...om the Southwest Oncology Group strongly suggests ...ncers early, when they are most easily treatable. ...
...arker, not a cause, of renal trouble, study sugges...-- Lowering blood levels of an inflammation-linke...th serious kidney disease live any longer, new res...e who took extra folic acid, vitamin B6 and vitami...
...11 Dr. Walter,Cottrell, Pennsylvania Game Commiss...e test result from an adult female deer has confir...een found in Beaver County., "This outbreak of EH...dition, the fact that we are finding EHD earlier,t...
...s Conclude Sweetener Is Safe Across Population ...Sept. 11 A report published in the,September issu...sue 8, pp.,629-727) systematically evaluates virtu...of eight recognized scientists,from research insti...
Other Medicine News:Health News:Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3Health News:Generic prostate drug helps find high-risk cancers early 2Health News:Generic prostate drug helps find high-risk cancers early 3Health News:Lowering Blood Protein Won't Help Kidney Patients 2Health News:Lowering Blood Protein Won't Help Kidney Patients 3Health News:PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County 2Health News:PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County 3Health News:PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County 4Health News:New Expert Report Dispels Common Myths About Aspartame 2Health News:New Expert Report Dispels Common Myths About Aspartame 3
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: